Subject to its devices receiving necessary U.S. Food and Drug Administration (FDA) approvals, Boston Scientific Corp. will have the capability to transmit implantable cardiac device data to physicians and other healthcare providers in North America across the AT&T wireless network in the future, AT&T announced.
Using its clinical expertise in remote patient monitoring, Boston Scientific plans to embed AT&T wireless technology in its Latitude Patient Management system, which will be utilized in the company's future lines of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators and pacemakers (CRT-Ds and CRT-Ps).
Boston Scientific's current remote monitoring system allows physicians the ability to conduct remote follow-up of implantable cardiac device patients to monitor specific device information and heart health status. The system can also detect clinical events between scheduled visits and send relevant data directly to a highly secure website that can be accessed by physicians. Future wireless connectivity under the new agreement will allow the transmission of data to physicians from most locations without the need for landline-based technology.
"There is no question that the convergence of healthcare and mobile technology is happening today and offers limitless opportunities in the future. We are very focused in helping drive this innovation. Together with Boston Scientific, we will enable more convenient care for patients and more opportunities for physicians," said Glenn Lurie, president of emerging devices for AT&T Mobility.
"Physicians are asking for flexible connectivity solutions for remote monitoring systems that can improve efficiency," said Joe Fitzgerald, senior vice president and president of the Cardiac Rhythm Management Unit for Boston Scientific. "Boston Scientific is pleased to collaborate with AT&T and benefit from its depth and breadth of cellular technology expertise to help physicians and their patients."
For more information: www.att.com.
May 04, 2020 
